Emcure Pharmaceuticals Limited — Credit Ratings, 08-10-2025: Credit Rating

CARE Ratings upgraded Emcure Pharma's long-term bank facilities to CARE AA; Stable from CARE AA-; Stable. Short-term facilities were reaffirmed at CARE A1+. The upgrade reflects sustained improvement in operational and financial risk profile, robust FY25 revenue growth to ₹7,902 Cr (up 18%), and a strengthened capital structure after IPO debt repayment. Outlook remains Stable.